Medically reviewed by Christine L. Larsen, MD Medically reviewed by Christine L. Larsen, MD Glaucoma is a group of eye ...

They administered the xylazine-based conjugates to mice and monitored how the mice moved and breathed when they were later ...

The centrally acting alpha2-adrenergic agonist allows for nighttime dosing and can be used with stimulants, the drug's ...

Tris Pharma on Wednesday secured the FDA’s green light for Onyda XR, the first liquid non-stimulant nighttime treatment for attention deficit hyperactivity disorder in pediatric patients.

In this article, we consider the difference between kratom and delta 8, two prominent compounds that have gained popularity ...

adrenergic, histaminergic or muscarinic receptors. While the specific way INGREZZA works to treat TD and HD chorea is not fully ...

In a study published in Cell Host & Microbe, a research team has demonstrated the causal link between microbial factors and ...

New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma          Late-breaking data presented at ATS show that treatment ...

At the recent SEC meeting for Cardiovascular held on 23rd April 2024, the expert panel reviewed the proposal for the BE study ...

Neurocrine Biosciences, Inc. , today announced that Kevin Gorman, Ph.D., will retire as Chief Executive Officer of Neurocrine on October 11, 2024. Kyle Gano, Ph.D., currently Neurocrine's Chief ...

Certain types of antidepressants can cause an adrenergic reaction, which has to do with your adrenaline levels, and lead to ...

RVL Pharmaceuticals announced today that its prescription eye drop, Upneeq® (oxymetazoline hydrochloride ophthalmic solution) ...